Cite
MLA Citation
Justin Benet et al.. “Survival of clinical stage III NSCLC according to therapeutic strategy: Relevance of the tumor board decision in the era of immunotherapy.” Cancer treatment and research communications, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100150511350.0x000002